Free Trial
OTCMKTS:GBCS

Selectis Health (GBCS) Stock Price, News & Analysis

Selectis Health logo
$1.51 0.00 (0.00%)
As of 05/27/2025

About Selectis Health Stock (OTCMKTS:GBCS)

Key Stats

Today's Range
$1.51
$1.51
50-Day Range
$1.51
$2.20
52-Week Range
$1.12
$2.50
Volume
N/A
Average Volume
2,462 shs
Market Capitalization
$4.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.

Receive GBCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Selectis Health and its competitors with MarketBeat's FREE daily newsletter.

GBCS Stock News Headlines

Selectis Health Delays Q1 2025 10-Q Filing
Selectis Health Delays Yearly Report Filing
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
Selectis Health Makes Key Leadership Announcement
Best Electric Wheelchairs Of 2024
See More Headlines

GBCS Stock Analysis - Frequently Asked Questions

Selectis Health's stock was trading at $1.12 at the start of the year. Since then, GBCS stock has increased by 34.8% and is now trading at $1.51.
View the best growth stocks for 2025 here
.

Selectis Health, Inc. (OTCMKTS:GBCS) announced its earnings results on Tuesday, May, 20th. The company reported ($0.22) earnings per share (EPS) for the quarter. The company had revenue of $10.49 million for the quarter.

Selectis Health shares reverse split on the morning of Wednesday, September 22nd 2021. The 1-10 reverse split was announced on Wednesday, September 22nd 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 22nd 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of GBCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Selectis Health investors own include Chemed (CHE), Walt Disney (DIS), OceanFirst Financial (OCFC), Celanese (CE), Credit Acceptance (CACC), Blackstone Mortgage Trust (BXMT) and Blackstone (BX).

Company Calendar

Last Earnings
5/20/2025
Today
5/28/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Real estate investment trusts
Sub-Industry
Trading
Current Symbol
OTCMKTS:GBCS
Employees
500
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.97 million
Pretax Margin
-14.31%

Debt

Sales & Book Value

Annual Sales
$36.78 million
Price / Cash Flow
N/A
Book Value
($1.22) per share
Price / Book
-1.24

Miscellaneous

Free Float
2,601,000
Market Cap
$4.63 million
Optionable
Not Optionable
Beta
-0.42
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:GBCS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners